Author/Creator: Ozaki, Ema - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Ozaki, Ema

1. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

Authors:: Kenna, Paul F; Humphries, Marian M; Kiang, Anna-Sophia; Brabet, Philippe; Guillou, Laurent; Ozaki, Ema; Campbell, Matthew; Farrar, G Jane; Koenekoop, Robert; Humphries, Pete
Journal:: BMJ open ophthalmology
Issue:: Volume 5:Issue 1(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

Authors:: Kenna, Paul F; Humphries, Marian M; Kiang, Anna-Sophia; Brabet, Philippe; Guillou, Laurent; Ozaki, Ema; Campbell, Matthew; Farrar, G Jane; Koenekoop, Robert; Humphries, Pete
Journal:: BMJ open ophthalmology
Issue:: Volume 5:Issue 1(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

Authors:: Kenna, Paul F; Humphries, Marian M; Kiang, Anna-Sophia; Brabet, Philippe; Guillou, Laurent; Ozaki, Ema; Campbell, Matthew; Farrar, G Jane; Koenekoop, Robert; Humphries, Pete
Journal:: BMJ open ophthalmology
Issue:: Volume 5:Issue 1(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

Authors:: Kenna, Paul F; Humphries, Marian M; Kiang, Anna-Sophia; Brabet, Philippe; Guillou, Laurent; Ozaki, Ema; Campbell, Matthew; Farrar, G Jane; Koenekoop, Robert; Humphries, Pete
Journal:: BMJ open ophthalmology
Issue:: Volume 5:Issue 1(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

Authors:: Kenna, Paul F; Humphries, Marian M; Kiang, Anna-Sophia; Brabet, Philippe; Guillou, Laurent; Ozaki, Ema; Campbell, Matthew; Farrar, G Jane; Koenekoop, Robert; Humphries, Pete
Journal:: BMJ open ophthalmology
Issue:: Volume 5:Issue 1(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

Authors:: Kenna, Paul F; Humphries, Marian M; Kiang, Anna-Sophia; Brabet, Philippe; Guillou, Laurent; Ozaki, Ema; Campbell, Matthew; Farrar, G Jane; Koenekoop, Robert; Humphries, Pete
Journal:: BMJ open ophthalmology
Issue:: Volume 5:Issue 1(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

Authors:: Kenna, Paul F; Humphries, Marian M; Kiang, Anna-Sophia; Brabet, Philippe; Guillou, Laurent; Ozaki, Ema; Campbell, Matthew; Farrar, G Jane; Koenekoop, Robert; Humphries, Pete
Journal:: BMJ open ophthalmology
Issue:: Volume 5:Issue 1(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

Authors:: Kenna, Paul F; Humphries, Marian M; Kiang, Anna-Sophia; Brabet, Philippe; Guillou, Laurent; Ozaki, Ema; Campbell, Matthew; Farrar, G Jane; Koenekoop, Robert; Humphries, Pete
Journal:: BMJ open ophthalmology
Issue:: Volume 5:Issue 1(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

Authors:: Kenna, Paul F; Humphries, Marian M; Kiang, Anna-Sophia; Brabet, Philippe; Guillou, Laurent; Ozaki, Ema; Campbell, Matthew; Farrar, G Jane; Koenekoop, Robert; Humphries, Pete
Journal:: BMJ open ophthalmology
Issue:: Volume 5:Issue 1(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. Interleukin‐33 regulates tissue remodelling and inhibits angiogenesis in the eye. Issue 1 (16th November 2016)

Authors:: Theodoropoulou, Sofia; Copland, David A; Liu, Jian; Wu, Jiahui; Gardner, Peter J; Ozaki, Ema; Doyle, Sarah L; Campbell, Matthew; Dick, Andrew D
Journal:: Journal of pathology
Issue:: Volume 241:Issue 1(2017)
Page Start:: 45
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗